Becton Dickinson: Christopher DelOrefice, Christopher Reidy

Becton Dickinson has named Christopher DelOrefice to be the firm's executive vice president and chief financial officer, effective Sept. 6. DelOrefice will succeed Christopher Reidy, who had served as BD's CFO for eight years. He joins the firm from Johnson & Johnson, where he was most recently vice president of investor relations and also served as CFO of J&J's consumer and medical devices segments among other finance positions. Reidy will now become a director of the company formed in connection with the separation of the BD diabetes care business into an independent, publicly traded company.